Dr. Russo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11100 Euclid Ave
University Of South Alabama Mitchell Cancer Institute
Cleveland, OH 44106Phone+1 216-844-3951
Education & Training
- University of North Carolina HospitalsResidency, Radiation Oncology, 1996 - 2000
- University of North Carolina HospitalsInternship, Internal Medicine, 1995 - 1996
- University of North Carolina at Chapel Hill School of MedicineClass of 1995
Certifications & Licensure
- OH State Medical License 2015 - 2026
- TN State Medical License 2005 - 2026
- AL State Medical License 2001 - 2025
- MS State Medical License 2005 - 2025
- NC State Medical License 1997 - 2025
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
Publications & Presentations
PubMed
- Executive Summary of the American Radium Society on Appropriate Use Criteria for Nonoperative Management of Rectal Adenocarcinoma: Systematic Review and Guidelines.Christopher J Anker, Leila T Tchelebi, J Eva Selfridge, Salma K Jabbour, Dmitriy Akselrod
International Journal of Radiation Oncology, Biology, Physics. 2024-11-15 - Executive Summary of the American Radium Society Appropriate Use Criteria for Neoadjuvant Therapy for Nonmetastatic Pancreatic Adenocarcinoma: Systematic Review and Gu...Krishan R Jethwa, Ed Kim, Jordan Berlin, Christopher J Anker, Leila Tchelebi
American Journal of Clinical Oncology. 2024-04-01 - 3 citationsAmerican Radium Society Appropriate Use Criteria for the use of liver-directed therapies for nonsurgical management of liver metastases: Systematic review and guidelines.Christopher L Hallemeier, Navesh Sharma, Christopher Anker, J Eva Selfridge, Percy Lee
Cancer. 2023-10-15
Grant Support
- EGFR TKI As A Radiosensitizer For Esophageal CancerNational Center For Research Resources2005
- EGFR TKI As A Radiosensitizer For Esophageal CancerNational Center For Research Resources2004
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: